Skip to main content
. 2024 Mar 15;19(3):e0299836. doi: 10.1371/journal.pone.0299836

Fig 4. The distribution of metabolic syndrome severity, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) prevalence and the adjusted odds of MASLD by metabolic syndrome severity, United States adults, the Third National Health and Nutrition Examination Survey (NHANES III), 1988–1994 (n = 10,605).

Fig 4

* To construct the Metabolic Syndrome Severity Group, the Metabolic Syndrome Z-score was transformed into four percentiles-based categories [low (0 – 50th), Moderate (>50th– 75th), High (>75th– 90th), and very-high (>90th)]. ** MASLD odds ratios in reference to mild severity adjusted for age, sex, and race/ethnicity.